Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MDMA-Assisted Therapy for Military Service Members With PTSD
NCT07704762Phase 2Not yet recruiting
- Sponsor
- U.S. Army Medical Research and Development Command
- Start
- Oct 2026
- Primary completion
- Jan 2028
01
Overview
A Phase 2 trial of midomafetamine in post-traumatic stress disorder (PTSD), sponsored by U.S. Army Medical Research and Development Command. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
midomafetamine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT07704762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07704762.